Cetera Investment Advisers Isoray, Inc. Transaction History

Cetera Investment Advisers

  • $42.2 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 24, 2024
BUY
N/A
12,500 New
12,500 $8,000
Q2 2023

Aug 09, 2023
SELL
$0.0 - $0.69 $0 - $13,799
-20,000 Reduced 23.53%
65,000 $44,000
Q4 2022

Feb 14, 2023
BUY
$0.24 - $0.4 $20,400 - $34,000
85,000 New
85,000 $20,000

Others Institutions Holding ISR

# of Institutions
4
Shares Held
287K
Call Options Held
0
Put Options Held
0
View Full List

About Isoray, Inc.

ISR Quotes by TradingView
  • Ticker ISR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 142,112,992
  • Market Cap $98.1M
  • Description
  • Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...
More about ISR
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email